it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. . blood-filled tick .
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." . .
related topics
-
.
OFF DEAL
218 Used Today
OFF DEAL
OFF DEAL
200 Used Today